Related Experiment Video

Updated: Dec 26, 2025

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.3K

MiR-449a attenuates autophagy of T-cell lymphoma cells by downregulating ATG4B expression

Nan Zhang1, Ling Qiu2, Tao Li3

  • 1Department of Hematology, The General Hospital of Western Theater Command, Chengdu 610083; Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Army Medical University, Chongqing 400038, China.

BMB Reports
|March 17, 2020
PubMed

Insights

MicroRNA-449a promotes T-cell lymphoma cell apoptosis by inhibiting autophagy, specifically by downregulating autophagy-associated 4B (ATG4B) expression. This miR-449a/ATG4B pathway offers a potential therapeutic target for T-cell lymphoma malignancy.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Autophagy is implicated in T-cell lymphoma malignancy.
  • The role of microRNA-449a (miR-449a) in T-cell lymphoma and its connection to autophagy remain unclear.

Discussion:

  • This study elucidates the novel mechanism by which miR-449a regulates T-cell lymphoma malignancy.
  • miR-449a enhances apoptosis by reducing autophagy.
  • The study identifies autophagy-associated 4B (ATG4B) as a direct target of miR-449a.

Key Insights:

  • miR-449a directly targets ATG4B mRNA 3'UTR, decreasing ATG4B protein levels and subsequently reducing autophagy.
  • Inhibition of autophagy by miR-449a leads to enhanced apoptosis in T-cell lymphoma cells.
  • In vivo studies in nude mice demonstrated that miR-449a significantly inhibits lymphoma progression.

Outlook:

  • The identified "miR-449a/ATG4B/autophagy" pathway represents a promising therapeutic strategy for T-cell lymphoma.
  • Further research into targeting this pathway could lead to novel treatments for lymphoma.

More Related Videos

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells09:10

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells

Published on: October 28, 2019

7.6K
Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry11:39

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry

Published on: July 21, 2017

32.1K

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K